Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, July 7, 2022

By and Large, Thrombectomy in Large Core Is a Palpable Reality

Well yes, you can do it, but you aren't measuring the most important outcome, 100% RECOVERY.

No measurement of 100% recovery. Bad research, the mentors and senior researchers need to be fired. 

“What's measured, improves.” So said management legend and author Peter F. Drucker 

The latest here:

By and Large, Thrombectomy in Large Core Is a Palpable Reality

Originally publishedhttps://doi.org/10.1161/STROKEAHA.122.039069Stroke. 2022;0:10.1161/STROKEAHA.122.039069

Our Japanese colleagues deserve much praise for finishing the first randomized clinical trial of thrombectomy in Alberta Stroke Program Early CT Score 3 to 5 patients showing an impressive therapy effect of thrombectomy. The predominant use of magnetic resonance imaging for patient selection, the low rate of alteplase therapy and its low dose limit direct comparisons with patients treated outside of Japan. Another limitation is the lack of benefit when using the traditional metric–modified Rankin Scale score 0–2. We consider the results of RESCUE-Japan LIMIT encouraging and a clear motivation to continue and complete other studies.

Footnotes

The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.

For Sources of Funding and Disclosures, see page xxx.

Correspondence to: Jens Fiehler, MD, Department of Neuroradiology, O22, University Center Hamburg-Eppendorf, Martinistrasse 52, 20251 Hamburg, Germany. Email

No comments:

Post a Comment